Stock PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Provectus Biopharmaceuticals, Inc.

Equities

PVCT

US74373P1084

Market Closed - OTC Markets
Other stock markets
 02:48:36 2024-07-16 pm EDT 		5-day change 1st Jan Change
0.108 USD -5.84% Intraday chart for Provectus Biopharmaceuticals, Inc. -27.27% +12.50%
May. 21 Provectus Biopharmaceuticals, Inc. Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting CI
May. 14 Provectus Biopharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROVECTUS BIOPHARMACEUTICALS, INC. Stock Provectus Biopharmaceuticals, Inc.
 48.12M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 117B
ARGENX SE Stock argenx SE
 27.67B -
BIONTECH SE Stock BioNTech SE
 20.33B -
GENMAB A/S Stock Genmab A/S
 16.79B
  1. Stock Market
  2. Equities
  3. PVCT Stock
  4. Charts Provectus Biopharmaceuticals, Inc.
  5. Sector Chart